Pentraxin-3 as a diagnostic and prognostic biomarker in inflammatory lung diseases

This publication has 92 references indexed in Scilit:

• Serum levels and gene expression of pentraxin 3 are elevated in COPD
  Advances in Medical Sciences, 2019
• Admission Pentraxin‐3 Level Predicts Severity of Community‐Acquired Pneumonia Independently of Etiology
  Proteomics – Clinical Applications, 2018
• Low serum fibroblast growth factor 2 levels not accompanied by increased serum pentraxin 3 levels in patients with systemic sclerosis
  Clinical Rheumatology, 2016
• Pentraxin 3 sputum levels differ in patients with chronic obstructive pulmonary disease vs asthma
  Annals of Allergy, Asthma & Immunology, 2015
• Pentraxin 3 as a clinical marker in children with lower respiratory tract infection
  Pediatric Pulmonology, 2015
• Pentraxin 3 as a Novel Biomarker of Inflammation in Chronic Obstructive Pulmonary Disease
  Inflammation, 2014
• Heterophilic antibody interference in immunometric assays
  Best Practice & Research Clinical Endocrinology & Metabolism, 2013
• Biospecimen reporting for improved study quality (BRISQ)
  Cancer Cytopathology, 2011
• Validation and updating of predictive logistic regression models: a study on sample size and shrinkage
  Statistics in Medicine, 2004
• Production of the soluble pattern recognition receptor PTX3 by myeloid, but not plasmacytoid, dendritic cells
  European Journal of Immunology, 2003